Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jan 30.
Published in final edited form as: Immunity. 2022 Nov 8;55(11):2206–2208. doi: 10.1016/j.immuni.2022.09.015

Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing

Brendan W MacNabb, Xiufen Chen, Sravya Tumuluru, James Godfrey, Darshan N Kasal, Jovian Yu, Marlieke LM Jongsma, Robbert M Spaapen, Douglas E Kline, Justin Kline *
PMCID: PMC9885954  NIHMSID: NIHMS1844724  PMID: 36351377

During figure reformatting late in the publication process, the flow cytometry plots shown in Figure 2F were inadvertently duplicated such that those showing production of IFN-γ by restimulated 2C T cells (top row of Figure 2F) were copied and mistakenly displayed for TNF-α (middle row) and Granzyme B (bottom row). The plots have been reverted to display the correct flow cytometry plots. Additionally, the name order for the authors has been updated to reflect contributions to the work during the revision process. The authors apologize for any confusion this may have caused.

Figure 2.

Figure 2.

Cancer cell Kb expression is required for optimal activation of Kb-restricted antigen-specific TCR-tg CD8+ T cells

RESOURCES